Influence of the vitrification solution on the angiogenic factors in vitrificated mouse ovarian tissue

Abstract

Objective

To investigate the effect of the dimethyl sulfoxide (DMSO) and EFS-40 during vitrification on the expression of angiogenic factors in vitrified mouse ovarian tissue.

Methods

The ovarian tissues were obtained from 5 or 6 weeks aged ICR mouse. Ovarian tissues were divided into four groups: ovarian tissue without cryopreservation (control, group I), ovarian tissue vitrified with 15% DMSO (group II), ovarian tissue vitrified with EFS-40 (group III), and ovarian tissue slowly frozen with 10% DMSO (group IV). Thawing was carried out at room temperature. Levels of messenger RNA (mRNA) and protein for vascular endothelial growth factor-A (VEGF-A) and angiopoietin-2 (Angpt-2) were checked in ovarian tissues of four groups recovered on day 7 after cryopreservation. Reverse transcription-polymerase chain reaction and Western blot analysis were used to identify the levels of angiogenic factors in mouse ovarian tissues.

Results

Levels of mRNA and protein for VEGF-A and Angpt-2 were significantly decreased in cryopreserved group (group II, III and IV) than control group (group I) (P< 0.05). The significant differences of levels of mRNA and protein for VEGF-A and Angpt-2 between cryopreservation methods were observed (P< 0.05). Group III showed highest expression of mRNA and protein for VEFG-A and Angpt-2 than other cryopreservation groups (P< 0.05).

Conclusion

These findings suggest that EFS-40 is more efficient vitrification solution for preservation of angiogenic factors than 15% DMSO during vitrification of mouse ovarian tissue. Future studies should investigate to improve the vitrification solution for ovarian tissue vitrification.

Introduction

Advances in the diagnosis and treatment of childhood, adolescent and adult cancer have greatly increased the life expectancy of premenopausal women with cancer but have resulted in a growing population and adult long-term survivors of childhood malignancies [1]. The cryopreservation of ovarian tissue is a promising technique for the preservation of fecundity in young female cancer patients after sterilization by chemotherapy and/or radiotherapy [2].

Probability to be early menopause after chemotherapy, although affected by many factors, it is the most important factors were patient's age, type and cumulative dose of the drugs. Primordial follicles are most likely to be effected than growing follicles and ovarian follicle should be stopped permanently destroys while receiving chemical injury to primordial follicles [3].

The limited length of ovarian function in some ovarian transplant cases using nonvascularized grafts may partially due to ischemic injury until revascularization occurs [4]. Therefore, the establishment of an effective blood supply and the development of angiogenesis are essential for the survival of cryopreserved ovarian tissue [5]. Ovarian tissue is able to produce angiogenetic factors that promote a neovascularization after transplantation. So, revascularization plays a critical role in successful ovarian tissue transplantation.

Vascular endothelial growth factor (VEGF) was known as 1) endothelial cell mitogen factor, 2) regulate permeability of blood vessels, 3) angiogenesis in transplanted ovarian tissue [6-8]. Angiopoietins were required for regulation of angiogenesis and blood vessel stabilization [9,10]. In presence of VEGF, angiopoietin-2 (Angpt-2) enables endothelial cell migration and proliferation, promoting further angiogenesis. In the absence of VEGF, Angpt-2 blocks the recruitment of periendothelial support cells, resulting in blood vessel destabilization and regression [11-13]. Also levels of Angpt-1 and Angpt-2 may be associated with follicular growth and angiogenesis during the preovulatory period [13].

Several cryopreservation of ovarian tissue cryopreservation methods being used, but vitrification is relatively simple and does not require expensive equipment and recent research has been relatively good results are presented [14]. Several vitrification solutions were used, but the impact on the ovarian tissue was not well known. In particular, there were few studies on the effects for angiogenic factors after vitrification. Thus, the objective of this study was to determine the effect of the dimethyl sulfoxide (DMSO) and EFS-40 during vitrification on the VEGF and Angpt-2 in vitrified mouse ovarian tissue.

Materials and methods

1. Animals

Female ICR mice were purchased from Koatech Co. (Pyeongtaek, Korea). The mice were housed under light-controlled and temperature-controlled conditions (12 hour of light and 12 hour of darkness; 22±2℃), and were provided with sterile food and water. Mice were treated in accordance with the standard guidelines for laboratory animal care at the animal facility of the Gyeongsang National University (GLA-090107-M0001).

2. Ovarian tissue collection

Twenty ICR mice aged 5 or 6 weeks old were sacrificed, and their ovaries were placed in a large sterile Petri dish with Ham's F-10 media. The ovaries were randomly assigned into four groups (each 10 ea): 1) ovarian tissue without cryopreservation (control, group I), 2) ovarian tissue vitrified with 15% DMSO (group II), 3) ovarian tissue vitrified with EFS-40 (group III), and ovarian tissue slowly frozen with 10% DMSO (group IV).

3. Cryopreservation

1) Vitrification

Ovarian tissues to be vitrified were immersed in an equilibration solution (EG-20) for 2, 5, and 10 minutes that consisted of 20% ethylene glycol (EG) in Dulbecco's phosphate-buffered saline (m-DPBS) with 10% fetal bovine serum (FBS), followed by immersion in a vitrification solution (15% DMSO in group II or EFS-40 in group III) for 2 minutes. EFS-40 was consisted of 40% EG (v/v), 18% ficoll (w/v), 0.5 mol/L sucrose, and 20% FBS in m-DPBS in group III. Then, the ovarian tissue were placed onto an electron microscope gird and submerged immediately in liquid nitrogen. After 1 week, the three step cryoprotectant dilution method (0.75 M, 0.5 M, 0.25 M sucrose) was performed to thaw the ovarian tissue.

2) Slow-freezing

Ovarian tissues were transferred to a cryovial containing the cryoprotective mixture (Leibovitz L-15 medium, 10% FBS, and 10% DMSO) for controlled freezing using Planar Cryochamber. Cooling was started at 4℃ and continue at 2℃/min until ice nucleation was induced at -7℃. The temperature was then reduced at 2℃/min until -35℃ and subsequently at 25℃/min until -140℃ before the cryovials were plunged into liquid nitrogen. After 1 week, thawing was carried out at room temperature.

3) RNA extraction and reverse transcription-polymerase chain reaction (RT-PCR)

Total RNA was isolated from ovarian tissues with TRIZOL (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. One microgram of total RNA was reverse-transcribed using SuperScript III RT (Invitrogen), random hexamers (50 pmol), and dNTPs (2.5 mM) at 37℃ for 20 minutes. Specific sequence of primer for VEGF-A, Angpt-2 was obtained from Gene Bank Database (Table 1). PCR reactions were carried out with the following programs, first heated to 94℃ for 4 minutes, then 30 cycles of denaturation at 94℃ for 40 second, annealing at 55℃ for 40 second, and extension at 72℃ for 40 second, and then final elongation step at 72℃ for 8 minutes. PCR products were analyzed by 2% agarose gel electrophoresis. Expression of each messenger RNA (mRNA) species was normalized to that of glyceraldehyde-3-phosphate dehydrogenase. Relative quantitation of the target gene expression was evaluated using SigmaGel software (Sigma, St. Louis, MO, USA).

Table 1.

Primers sequence of VEGF-A and Angpt-2

VEGF-A, vascular endothelial growth factor-A; Angpt-2, angiopoietin-2; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

4. Western blot analysis

Mouse ovarian tissues were preserved in Pro-prep (iNtRON, Seongnam, Korea) solution until analysis. Proteins were separated by SDS-PAGE in 8% to 12% gels and blotted onto polyvinylidene difluoride membrane. The blots were blocked with 5% skim-milk in TBST (20 mM Tris-buffered saline and 0.05% Tween 20, pH 7.5) at room temperature for 1 hour and incubated overnight at 4℃ with VEGF-A (1:500; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), angpt-2 (1:1,000; Santa Cruz Biotechnology Inc.) and β-actin (1:10,000; Sigma) anti-VEGF antibody (1:500). Blots were then washed and incubated with secondary antibody, followed by washing and detection of immunoreactivity with enhanced chemiluminescence (Amersham Biosciences, Piscataway, NJ, USA). For quantitation of the result, each band density was read by SigmaGel software (Sigma). Each protein expression level was the normalized relative quantitative values using each corresponding β-actin expression level as an internal control.

5. Statistical analysis

The data were represented as the mean ± standard error. Statistical analyses were performed using PASW ver. 18.0 (SPSS Inc., Chicago, IL, USA). Non-parametric Kruskal-Wallis test was used and Tukey test using ranks for post-hoc analysis. The level of significance was set at P<0.05.

Results

1. Impaired effects on angiogenic factors after cryopreservation

In cryopreservation group (group-II, III, IV), levels of mRNA and protein for angiogenic factors (VEGF-A and Angpt-2) were significantly decreased than control group (group I) (P<0.05) (Figs. 1, 2).

Fig. 1.

Reverse transcription-polymerase chain reaction analysis of mRNA levels for (A) VEGF-A and (B) Angpt-2 after variable cryopreservation methods and quantitative analysis of each group. GAPDH was used as internal standard. The data represents mean±standard error of three independent experiments. DMSO, dimethyl sulfoxide; EFS, 40% EG, 18% ficoll, 0.5 mol/L sucrose, and 20% FBS in modified Dulbecco's phosphate buffered saline; Angpt-2, angiopoietin-2; VEGF-A, vascular endothelial growth factor-A; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. ^a)P<0.05 vs. cryopreservation groups (vitrification using DMSO, EFS, and slow freezing; ^b)P<0.05 vs. other cryopreservation groups (vitrification using DMSO and slow freezing).

Fig. 2.

Western blot analysis of (A) VEGF-A and (B) Angpt-2 after variable cryopreservation methods and quantitative analysis of each group. β-Actin was used as internal standard. The data represents mean±standard error of three independent experiments. DMSO, dimethyl sulfoxide; EFS, 40% EG, 18% ficoll, 0.5 mol/L sucrose, and 20% FBS in modified Dulbecco's phosphate buffered saline; Angpt-2, angiopoietin-2; VEGF-A, vascular endothelial growth factor-A. ^a)P<0.05 vs. cryopreservation groups (vitrification using DMSO, EFS, and slow freezing); ^b)P<0.05 vs. other cryopreservation groups (vitrification using DMSO and slow freezing).

2. Analyzing the mRNA expressions between cryopreservation method

The significant differences of mRNA for VEGF and Angpt-2 between cryopreservation methods were observed (P<0.05) (Fig. 1). The mRNA for VEGF-A and Angpt-2 were highest in group III than group II and group IV (Fig. 1).

3. Different proteins expression between cryopreservation methods by Western blotting

The expressions of VEGF-A and Angpt-2 were significantly increased in group-III than in other cryopreservation groups (group II and IV) (P<0.05) (Fig. 2). In vitrification group, EFS-40 used as vitrification solution (group III) showed significantly increased levels of VEGF-A and Angpt-2 than 15% DMSO (group II) (P<0.05) (Fig. 2).

Discussion

Ovarian tissue has been successfully cryopreservated and transplanted into rodents, rabbits, sheep, and monkeys [15-17]. The problem to be solved was fall in the number of primodial follicles in ovarian tissue is due to hypoxia and vascular injury, probably resulting from osmotic damage or chemical toxicity from cryoprotectant agents [18]. The loss of primodial follicles in cryopreserved ovarian tissue after transplantation is estimated to be 50% to 65% [19,20] in some studies and >90% in one study [21].

VEGF was defined characterized for its ability to induce vascular leak and permeability, as well as for its ability to promote vascular cell proliferation [22]. Incubation with hyalunonan and VEGF of human ovarian tissue can improves graft survival [23]. So, VEGF is an important factor that can predict the success of the transplantation of cryopreserved ovarian tissue. In this experiment, the reduction of VEGF-A occurred after the all of cryopreservation method. We suggested that lower reduction of VEGF-A in vitrification using EFS-40 than vitrification using DMSO and slow-freezing should be to contribute to the success of transplantation of the cryopreserved ovarian tissue.

Slow freezing of ovarian tissue has been indicated because of the preservation of cell morphology and hormone production after freezing-thawing of ovarian tissue [24]. However, vitrification of ovarian tissue also resulted in preserved follicular morphology and viability and stromal density [25,26]. Indeed, several studies have shown no differences when slow freezing and vitrification were compared regarding tissue revascularization after transplantation [27]. In present study, the differences of angiogenic factors expression were observed between the vitrification using EFS and slow freezing groups. Also, the reduction of angiogenic factors has been observed when using DMSO when compared to EFS-40 as vitrification cryoprotectant. Such a decrease might be caused by the osmotic stress to which cells are exposed during vitrification and toxicity of cryoprotectants. So, vitrification could be offered as an alternative method to reduce the damage of angiogenic factors while cryopreservation of ovarian tissue and EFS-40 could be efficient vitrification solution for preservation of VEGF-A and Angpt-2 during vitrification of mouse ovarian tissue. Future studies should investigate vitrification solution for improving preservation of angiogenic factors that should be essential role for revascularization after implantation of cryopreserved ovarian tissue.